Combination chemotherapy with irinotecan and cisplatin in pretreated patients with unresectable or recurrent gastric cancer

By Ueda Shinya   Hironaka Shuichi   Boku Narikazu   Fukutomi Akira   Yoshino Takayuki   Onozawa Yusuke  

Gastric Cancer, Vol. 9, Iss. 3, 2006-08 ,pp. : 203-207

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of mitomycin C and cisplatin in heavily pretreated advanced breast cancer

By Hu Xichun   Guo Haiyi   Zhao Xinmin   Wang Zhonghua   Yang Xinmiao   Liu Xiangjin   Li Jin  

The Chinese-German Journal of Clinical Oncology, Vol. 5, Iss. 6, 2006-12 ,pp. : 442-445

Springer Publishing Company

Access to resources Recommend Favorite

Phase I Study with a Weekly 1 h Infusion of Paclitaxel in Heavily Pretreated Patients with Metastatic Breast and Ovarian Cancer

By Klaassen U.   Wilke H.   Strumberg D.   Eberhardt W.   Korn M.   Seeber S.  

European Journal of Cancer, Vol. 32, Iss. 3, 1996-03 ,pp. : 547-549

Elsevier

Access to resources Recommend Favorite

The Costs and Efficacy of Liposomal Doxorubicin in Platinum-Refractory Ovarian Cancer in Heavily Pretreated Patients

By Hensley M.L.   Hoppe B.   Leon L.   Sabbatini P.   Aghajanian C.   Chi D.   Spriggs D.R.  

Gynecologic Oncology, Vol. 82, Iss. 3, 2001-09 ,pp. : 464-469

Elsevier

Access to resources Recommend Favorite

Feasibility study of oral cyclophosphamide salvage therapy for the treatment of heavily pretreated patients with recurrent epithelial ovarian cancer

By Watanabe Yoh   Etoh Tomomaro   Koike Eiji   Mizuno Yoshiaki   Wang Wei-Min   Hoshiai Hiroshi  

International Journal of Clinical Oncology, Vol. 15, Iss. 5, 2010-10 ,pp. : 468-471

Springer Publishing Company

Access to resources Recommend Favorite